Filing Details

Accession Number:
0000898432-20-000015
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-03 19:24:55
Reporting Period:
2019-12-31
Accepted Time:
2020-01-03 19:24:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325618 Iradimed Corp IRMD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1254747 Brent Johnson C/O Iradimed Corporation
1025 Willa Springs Dr.
Winter Springs FL 32708
Exec. Vp. Sales And Mktg No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-31 617 $0.00 3,183 No 4 M Direct
Common Stock Disposition 2019-12-31 243 $23.38 2,940 No 4 F Direct
Common Stock Acquisiton 2019-12-31 6,000 $0.93 8,940 No 4 A Direct
Common Stock Disposition 2019-12-31 6,000 $23.79 2,940 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2019-12-31 617 $0.00 617 $0.00
Common Stock Stock Option(Right to Buy) Disposition 2019-12-31 6,000 $0.00 6,000 $0.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
126,468 2022-11-01 No 4 M Direct
Footnotes
  1. Restricted stock units convert into common stock on a one-for-one basis.
  2. On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
  3. The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.
  4. This transaction was executed in multiple trades at prices ranging from $23.65 to $23.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.